Airway Management proudly announces a historic milestone with the FDA clearance of Nylon flexTAP ® , the world’s first digitally printed single-point midline oral appliance device for sleep apnea.

People with both type 2 diabetes (T2D) and obstructive sleep apnea have a higher risk of death, but treatment with continuous ...

Results from a multicenter clinical trial, now published in the European Journal of Pediatrics, represent a significant milestone in the fight against one of the most underdiagnosed and undertreated ...

Philips Respironics has issued another ventilator recall deemed the most serious type by the FDA as it may cause serious injury or death.

For a potentially serious medical condition, it’s remarkable how few people know they have obstructive sleep apnea (OSA). The good news is that for people with a diagnosis, there have never been more ...

Polaris Market Research recently published a research report on “Sleep Apnea Devices Market Share, Size, Trends & Industry Analysis Report, By Diagnostic Devices (PSG, Respiratory polygraphs, Pulse ...

Nyxoah announced today that it filed a lawsuit against Inspire Medical Systems alleging the infringement of sleep apnea ...

Philips Respironics has removed certain DreamStation devices due to programming errors that can result in failed therapy modes, according to the U.S. Food and Drug Administration.

WASHINGTON - A massive recall of millions of sleep apnea machines has stoked anger and frustration among patients, and U.S. officials are weighing unprecedented legal action to speed a replacement ...

Despite media reports suggesting a fresh investigation, France has not initiated a new probe into Philips' recall of sleep ...

There is currently no drug that treats sleep apnea. However, the third clinical trial of AD109 suggests there could be one in the future. Taylor Leamey wrote about all things wellness for CNET, ...